DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹30 Cr | ₹24 Cr | ₹20 Cr | ₹26 Cr | ₹51 Cr |
What is the latest Long Term Provisions ratio of DR REDDYS LABORATORIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹24 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹26 Cr |
| Mar2021 | ₹51 Cr |
How is Long Term Provisions of DR REDDYS LABORATORIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | 24.69 | |
| Mar2024 | ₹24 Cr | 20.10 | |
| Mar2023 | ₹20 Cr | -22.87 | |
| Mar2022 | ₹26 Cr | -49.21 | |
| Mar2021 | ₹51 Cr | - | |
Compare Long Term Provisions of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹109,048.8 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
| MANKIND PHARMA | ₹88,961.6 Cr | 5.8% | 1.9% | -13.1% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 2.1% |
6.7% |
11.6% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses